Remdesivir in the Treatment of COVID-19: A Propensity Score-Matched Analysis from a Public Hospital in New York City Assessing Renal and Hepatic Safety

While the relative efficacy of remdesivir as a therapeutic agent in selected patients with COVID-19 has been established, safety concerns have been raised regarding potential nephrotoxicity and hepatotoxicity. Our main objective was to investigate the kidney- and liver-related safety outcomes in pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Hyomin, Palaiodimos, Leonidas, Berto, Cesar G., Tedunjaiye, Oluwatitomi, Malik, Paras, Nagraj, Sanjana, Choi, Hansol, Hti Lar Seng, Nang San, Kladas, Michail, Kharawala, Amrin, Karamanis, Dimitrios, Varma, Nidhi, Anjali, Acharya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181125/
https://www.ncbi.nlm.nih.gov/pubmed/35683518
http://dx.doi.org/10.3390/jcm11113132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181125/
https://www.ncbi.nlm.nih.gov/pubmed/35683518
http://dx.doi.org/10.3390/jcm11113132

Ejemplares similares